Regular monitoring includes HbA1c every 36 months, renal function, weight, blood pressure, injection sites, and diabetic retinopathy screening
Research from clinical trials, particularly the STEP 1 extension study (primarily using the higher 2.4 mg Wegovy dose), indicates that much of the weight lost during treatment may return over subsequent months, particularly if dietary and exercise habits revert to pre-treatment patterns
Are There Oral GLP-1 Agonist Drugs Available
top of page Neo Helix labs Home About Us Contact Career Shop More Use tab to navigate through the menu items
[2] The medication has a half-life of approximately one week, meaning it remains active in your system throughout the dosing interval
With outcomes like these, its no surprise that tirzepatide is quickly becoming a game-changer in the weight loss space, especially for patients with a BMI over 30 whove struggled with other methods